Fateme Eskandari, Alireza Razavian, Razieh Zare, Shayan Ejlali, Alireza Razmahang, Milad Zanjani, Seyedeh Sara Aghili, Mohammad Amin Mahdiyar, Hossein Mofidi, Kamyar Abbasi, Ashkan Badkoobeh, Nafiseh Shamloo, Lotfollah Kamali Hakim, Ahmed Hussain, Hamid Tebyaniyan
BACKGROUND: BIRC6, regarded as the pivotal member of the inhibitor of the apoptosis (IAP) family, has been linked to the development of different types of cancer in humans. The objective of this study was to examine the expression of BIRC6 in various oral conditions, including OLP with dysplasia (OLPD), hyperkeratosis (HK), OLP, epithelial dysplasia (ED), and oral squamous cell carcinoma (OSCC), to investigate its potential involvement in the development of OSCC and the pathogenesis and malignant transformation of OLP, which is known as a precancerous condition...
November 29, 2023: Diagnostics